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ABSTRACT
Patients with obstructive sleep apnea (OSA) are at risk for perioperative
respiratory and cardiovascular compromise (Opperer et al., 2016). Unfortunately, almost
90% of patients with moderate-to-severe OSA are not diagnosed and unaware of their
disorder; however, they remain at increased perioperative risks (Singh et al., 2015). The
STOP-BANG questionnaire was developed to meet the need for a reliable, concise, and
efficient screening tool for OSA risk. The facility at which this project was conducted
did not utilize a prescreening OSA risk tool. The facility not using a prescreening OSA
risk tool is especially important because the State of Mississippi currently ranks as one of
the most obese states in the nation, and because obesity positively correlates as one of the
greatest risk factors for having OSA (National Heart, Lung, and Blood Institute [NHLBI],
2018).
The purpose of this project was to determine the incidence and prevalence of
OSA, best anesthesia practice guidelines, and perioperative cardiac and respiratory
complications following implementation of the STOP-BANG questionnaire. A
retrospective chart review was completed the month prior to, during, and after the
implementation of the STOP-BANG questionnaire. De-identified data was provided by a
facility employee.
The calculated prevalence of patients identified as having moderate to high risk of
having OSA was 2.8%. During the month of implementation, 2% of patients who met
inclusion criteria had completed STOP-BANG questionnaires. Awareness of best
practice anesthesia guidelines resulted in a decrease in narcotic usage and an increase in
paralytic and reversal agents. Perioperative cardiovascular complications (arrhythmias
ii

and/or hypotension) during the month of implementation showed a decrease of 0.8%
along with a decrease of 4.7% in ICU admissions. Perioperative respiratory
complications such as hypoxemic events (oxygen saturation <85%) increased by 6.2%
and reintubations in the post-anesthesia care unit (PACU) had no change during the
month of implementation.
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CHAPTER I – INTRODUCTION AND BACKGROUND
Obstructive sleep apnea (OSA) affects millions of Americans with many of them
undiagnosed and untreated due to the signs and symptoms occurring during sleep
(National Heart, Lung, and Blood Institute [NHLBI], 2018). Unfortunately, almost 90%
of patients with moderate-to-severe OSA are not diagnosed and are left completely
unaware of their disorder; however, they have increased postoperative risks secondary to
this issue (Singh et al., 2015). The correlation of OSA with cardiovascular disease and
mortality was first reported in clinical cases nearly 30 years ago and has since been
confirmed over the years through numerous prospective observational studies involving
sleep clinic patients and community-based cohorts (Gottlieb, 2017). The lack of
awareness, routine screening, significant cost, and an insufficient number of sleep study
facilities to diagnose OSA via polysomnography (PSG) play a key role in the number of
undiagnosed cases (Dixon, Haas, Klopp, & Carlson, 2016). A prescreening tool, such as
the STOP-BANG questionnaire, can be implemented preoperatively to decrease the
number of undiagnosed OSA patients and their perioperative complications (Singh et al.,
2013).
Undiagnosed OSA may be associated with a variety of perioperative concerns
(e.g., difficult intubation, postoperative complications, increased admission to the
intensive care unit [ICU], and longer hospitalization) and a three to six-fold increase in
morbidity and mortality (Singh et al., 2013). Perioperative respiratory complications may
also manifest in cardiac alterations. According to the NHLBI (2018), OSA correlates
with an increased risk of high blood pressure, myocardial infarction, cerebral vascular
accident, obesity, diabetes, glaucoma, and premature births.
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OSA is defined as the absence of airflow or apnea for a minimum of 10 seconds
despite ventilatory efforts 5 or more times an hour (Spence, Han, McGuire, & Couture,
2015). The standard for diagnosis of OSA is observed PSG by a trained healthcare
provider (Kapur et al., 2017). PSG measures sleep cycles (rapid eye movement [REM]
and non-REM) with multiple sensors attached to the body recording brain waves, oxygen
levels, body position, breathing effort and rate, muscle activity, lung air flow, eye
movement, and heart rate. The severity of OSA is quantified with an apnea-hypopnea
index (AHI) per hour of sleep via PSG with mild scoring an AHI of 5 to 15, moderate 15
to 30, and severe OSA as an AHI greater than 30 (Dixon et al., 2016).
Anatomical changes associated with OSA patients may include a narrowed
pharyngeal airway secondary to excess adipose tissue, decreased neuromuscular tone of
the dilator muscles (genioglossus, tensor palatine, and hyoid muscles), and/or loss of
airway dilator reflexes resulting in obstruction of flow (Spence et al., 2015). Chronic
obstruction to flow, or apnea, reduces alveolar oxygen tension leading to pulmonary
vasoconstriction (decreased nitric oxide levels and increased endothelin levels),
pulmonary hypertension (HTN), and increased reactive oxygen species (ROS) in the
pulmonary artery smooth muscle cells creating a phenotypical change (Kholdani, Fares,
& Mohsenin, 2015). Pulmonary changes associated with OSA account for increased
perioperative complications such as reintubation, pneumonia, and pulmonary embolism
(Zaremba, Mojica, & Eikermann, 2016).
During obstructive respiratory events, electroencephalography (EEG) displays
microarousals from increased ventilatory events signifying sleep fragmentation (Spence
et al., 2015). Regulation of normal inspiration is mainly controlled by the dorsal
2

respiratory group of neurons (mainly the nucleus of the tractus solitarius) located along
the medulla (Guyton & Hall, 2016). During periods of apnea, increased levels of carbon
dioxide readily cross the blood-brain barrier and react with water to form carbonic acid.
Carbonic acid dissociates into hydrogen and bicarbonate ions; the hydrogen ions
stimulate the chemosensitive area located bilaterally just beneath the ventral surface of
the medulla. The chemosensitive area, in turn, excites the dorsal and ventral respiratory
groups along with the pneumotaxic center to increase the strength of motor signals to the
respiratory muscles. When the stimulus is strong enough, serotonergic and noradrenergic
neurons send excitatory impulses to the upper airway motor neurons, increasing dilator
muscle activity and arousal (Zaremba et al., 2016). Microarousals interrupt the normal
three to five REM sleep cycles that are responsible for mental recovery (Spence et al.,
2015). Fragmented sleep patterns may lead to delirium which is associated with
increased mortality, morbidity, as well as long-term cognitive and functional decline
(Zaremba et al., 2016).
OSA is an independent risk factor for congestive heart failure, arrhythmias,
myocardial ischemia, systemic hypertension, stroke, heart failure, and sudden cardiac
death (Kholdani et al., 2015). Cyclic hypoxemia and hypercapnia increase sympathetic
activity resulting in elevated levels of noradrenaline plasma levels, catecholamines in
urine, and muscle activity (Roca & Shah, 2015). Shifts in intrathoracic pressures due to
inspiratory efforts against an obstruction change ventricular loading, increasing
intracardiac transmural pressures and changes in autonomic activity (Roca & Shah,
2015). Finally, hypoxemia can lead to the formation of ROS, activating inflammatory
pathways such as C-reactive proteins and cytokines, which have been implicated in
3

atherosclerosis (Roca & Shah, 2015). The resulting systemic hypertension increases the
workload of the left ventricle leading to hypertrophy, diastolic failure, pulmonary
hypertension, right ventricular failure, and eventually, biventricular failure (Roca & Shah,
2015).
Although PSG is the standard for diagnosing OSA, it is neither practical for rapid
screening in a fast-paced preoperative environment nor feasible due to unplanned surgical
procedures, cost, and inadequate available resources (Dixon et al., 2016). The American
Academy of Sleep Medicine recommends that routine health maintenance evaluations
incorporate questions evaluating OSA risk factors (U.S. Preventive Services Task Force
[USPSTF], 2017). The American Society of Anesthesiologists (ASA) and the Joint
Commission recommend the screening of all surgical patients for the risk of OSA;
moreover, the Society of Ambulatory Anesthesia (SAMBA) recommends the use of the
STOP-BANG questionnaire as a preoperative screening tool to identify a patient’s risk
for OSA (Stierer & Collop, 2015).
The STOP-BANG questionnaire (Appendix A) was developed to meet the need
for a reliable, concise, and efficient screening tool for OSA risk that consists of four
yes/no questions and four demographic characteristics. The yes/no questions are listed
as: do you snore loud enough to be heard from another room, are you tired during the
day, has anyone observed you stop breathing during sleep, and do you have
hypertension? The patient characteristics consist of body mass index (BMI) greater than
30, age older than 50, neck circumference greater than 17 inches for men and 16 inches
for women, and gender with male scoring a point. STOP-BANG scores range from zero
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to eight, with scores greater than three associated with moderate to severe OSA risk
(Chung, Abdullah, & Liao, 2016a).
One important key demographic of the STOP-BANG questionnaire includes a
BMI greater than 30 (obesity). Obesity is one of the most prevalent risk factors for OSA
(70% of patients diagnosed with OSA are obese) and affects approximately 500 million
adults worldwide (Peromaa-Haavisto et al., 2015). According to the Trust for America’s
Health and the Robert Wood Johnson Foundation (2017), Mississippi ranks second to
West Virginia as being the most obese state in the United States, is number one for high
school obesity, and just over 37% of its residents are obese. An obese patient generates
40% more in medical expenses per year than a non-obese patient and is projected to cost
Mississippi $3.9 billion in 2018 (Forrest General Hospital, 2016). Obesity has become
one of the greatest public health concerns and is known to be the most important risk
factor for OSA, thus a routine screening for OSA, especially with bariatric surgery, is
warranted (Peromaa-Haavisto et al., 2015). Furthermore, with rates of obesity increasing,
one can expect a higher prevalence of OSA (Zaremba et al., 2016).
This quality improvement (QI) project consisted of five distinct components. The
first component was the implementation of the STOP-BANG questionnaire. Secondly,
the STOP-BANG tool was utilized to determine the incidence and prevalence of OSA at
a Mississippi hospital and the comparison of anesthesia management with best practice
guidelines. Additionally, this quality improvement project focused on the number of
perioperative cardiovascular complications (arrhythmias, hypotension, and postoperative
admission to ICU) and respiratory complications (hypoxic events, reintubations, and
postoperative admission to the ICU) during the month before, during, and after the
5

implementation of the STOP-BANG questionnaire on all adult elective surgery
patients—excluding obstetrics, emergencies, and patients under the age of 18 years old.
For this project, hypoxic events are defined as oxygen saturation (SpO2) decreasing
below 85%, arrhythmias are defined as any rhythm other than normal sinus rhythm
(NSR) or paced rhythm, and hypotension is defined as systolic blood pressure (SBP) less
than 90 mmHg. This project was part of a larger quality improvement to assess the need
for a preoperative OSA prescreening tool, such as the STOP-BANG questionnaire.
Problem Statement
OSA affects approximately 24% of the population and 90% of individuals with
OSA remain undiagnosed (Singh et al., 2013). OSA can affect up to 77% of surgical
patients depending on the subpopulation with bariatric being the highest (Zaremba et al.,
2016). Patients at risk for OSA without previous diagnosis have increased rates of
mechanical ventilation, reintubation, hypoxemic events (SpO2 < 85%), longer surgical
durations, and other comorbidities (Fernandez-Bustamante et al., 2017). Furthermore, a
considerable proportion (76%-97%) of surgical patients at risk for OSA but undiagnosed
are not recognized by physicians, anesthetists, and surgeons prior to surgery (Singh et al.,
2013).
Screening tools exist to identify patients at risk for OSA; however, they are often
not utilized. The STOP-BANG questionnaire (prescreening tool) was originally
developed for use in the surgical setting and has proven to be effective (validated) in
identifying patients at risk for OSA (Nagappa et al., 2015). No prescreening tool for
OSA risk, including STOP-BANG, is utilized at a hospital in Southern Mississippi
preoperatively. The absence of an OSA screening tool leaves this disease a potentially
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underdiagnosed and undertreated problem that can lead to significant postoperative
respiratory and cardiovascular consequences such as hypoxemic events (SpO2 < 85%),
reintubations, arrhythmias, hypotension (SBP < 90 mmHg), and unintended admission to
the ICU.
In response to an ever-increasing prevalence of patients with diagnosed or
suspected OSA, guidelines have been developed for their anesthesia care. The ASA,
SAMBA, and the Society of Anesthesia and Sleep Medicine (SASM) have published
guidelines related to anesthesia management for these patients. Early identification of
OSA patients via the STOP-BANG questionnaire would assist in the implementation of
these guidelines by anesthesia providers.
Available Knowledge
An online search consisting of queries ranging from 2010 to 2018 was conducted
using multiple sources (MEDLINE, Embase, Cochrane Central Register of Controlled
Trials, Cochrane Databases of Systematic Reviews, Google Scholar, Web of Sciences,
Scopus, CINAHL and PubMed) searching for articles related to OSA, anesthesia
guidelines, best practices, respiratory complications, cardiovascular complications,
STOP-BANG, anesthesia, OSA, emergence, and best practice guidelines, single and in
combination. Study designs such as randomized control trials, cohort studies, prospective
and/or retrospective studies, meta-analyses, and systematic reviews of adult surgical
patients (>18 years old), were published in the English language and required to define
the presence of OSA risk. Exclusion criteria included irrelevant studies, non-diagnostic
studies, insufficient data, and no gold standard tests. A total of 7 study designs were
referenced for available knowledge.
7

Prevalence
As the rate of obesity increases across the United States, the prevalence of OSA
increases as well (National Heart, Lung, and Blood Institute, 2017). According to the
Centers for Disease Control and Prevention (CDC) (2018b), the prevalence of obesity in
the United States is 39.8%, Hispanics and non-Hispanic blacks have the highest
prevalence of obesity followed by non-Hispanic whites and Asians. In Mississippi, more
than 35% of adults are considered obese. These patients frequently experience episodes
of hypercarbia, oxygen desaturation, and increased somnolence (Lee, Nagubadi, Kryger,
& Mokhlesi, 2008). Depending on the severity of OSA and the period of time the patient
has been living with it, patients can be more susceptible to the respiratory depressant
effects of narcotics and more easily develop an upper airway obstruction (Porhomayon,
Nader, Leissner, & El-Solh, 2012).
Studies in the United States have shown that an estimated 93% of women and
82% of men with moderate to severe OSA have never been formally diagnosed
(Fassbender, Herbstreit, Eikermann, Teschler, & Peters, 2016). Cardiovascular mortality
rates have been higher in patients with untreated OSA (Hopps & Caimi, 2015). One
study has shown that almost 60% of anesthesia providers and 92% of surgeons failed to
identify patients with pre-existing OSA (Singh et al., 2013). These numbers demonstrate
an avoidable potential perioperative risk that patients are subjected to each time they
present for surgery.
According to the World Health Organization (2006), approximately 500 million
adults in the world are obese. Obesity by itself increases patients’ risk for developing
cardiovascular diseases, diabetes, and cancer (Peromaa-Haavisto et al., 2015). Obesity is
8

the most important risk factor for OSA, approximately 70% of patients with OSA are
classified as being obese. OSA affects mostly middle-aged men and women (PeromaaHaavisto et al., 2015). Approximately 80-90% of patients with OSA worldwide are
undiagnosed (Peromaa-Haavisto et al., 2015). Obesity costs the United States about $150
billion per year, with medical costs being $1,429 higher than the cost of someone with a
normal weight (CDC, 2018b). In Mississippi, $925 million was spent on healthcare costs
related to obesity in 2008. An estimated 22 million people in the United States suffer
from OSA (American Sleep Apnea Association, n.d).
STOP-BANG Tool
A high percentage (82%) of family physicians believe OSA is clinically
important, but only 11% of sleep complaints during a review of systems received further
workup (Wolfe, Pomerantz, Miller, Weiss-Coleman, & Solomonides, 2016). The lack of
preoperative OSA screening and sporadic identification of known OSA patients among
health care providers have become particularly serious for surgical patients due to
increased perioperative morbidity (Dixon et al., 2016). Singh et al. (2013) found that
93% of patients who were not diagnosed with OSA preoperatively were classified as at
risk by the STOP-BANG questionnaire.
The USPSTF (2017) recognizes the need for a clinical prediction tool that can
accurately determine which persons would benefit from further evaluation and testing for
OSA. Dixon et al. (2016) found a 25% increase in the detection of risk for OSA by
implementing the STOP-BANG questionnaire preoperatively on 1,625 patients over three
months. Singh et al. (2013) also found that by utilizing the STOP-BANG questionnaire
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preoperatively, 708 undiagnosed OSA patients were recognized at risk for OSA and that
after follow-up with PSG, 69% were identified as having OSA.
The STOP-BANG questionnaire was developed to meet the need for a reliable,
concise, and efficient screening tool for OSA risk that consists of four yes/no questions
and four demographic characteristics. The yes/no questions are listed as: do you snore
loud enough to be heard from another room, are you tired during the day, has anyone
observed you stop breathing during sleep, and do you have hypertension? The patient
characteristics consist of body mass index (BMI) greater than 30, age – older than 50,
neck circumference greater than 16 inches, and gender with male scoring a point. STOPBANG scores range from zero to eight with scores greater than three associated with
moderate to severe OSA risk (Chung et al., 2016a).
A STOP-BANG score of three to six has a negative predictive value (NPV)—the
probability that a negative screen equals no risk of disease—of 90% with a probability of
OSA increasing from 18% to 60% for moderate risk (Chung et al., 2016a). Furthermore,
a STOP-BANG score of seven to eight has an NPV of 100% with a probability of severe
OSA rising from 4% to 38% (Chung et al., 2016a). The STOP-BANG questionnaire can
identify patients with moderate to severe OSA with 93% sensitivity (true positive for
disease), 43% specificity (truly negative for disease), a positive predictive value (PPV)—
the probability that a positive screening results in having the disease—of 52%, and a
NPV of 90% (Singh et al., 2013).
A meta-analysis conducted by Nagappa et al. (2015) encompassed 9,206 adult
patients (11 studies in sleep clinics and 3 studies in the surgical population) and found
that as STOP-BANG scores increased greater than three, an increase in the probability of
10

moderate-to-severe OSA was noted. The validity of STOP-BANG scores were
confirmed by referencing PSG studies (Nagappa et al., 2015). Predictive parameters of
the STOP-BANG questionnaire in the surgical population for moderate OSA are listed as
prevalence 39.2%, sensitivity of 91%, negative predictive value (NPV) 84%, positive
predictive value (PPV) 46%, and a specificity of 32% (Nagappa et al., 2015). Severe
OSA predictive parameters of STOP-BANG in the surgical population are listed as a
prevalence of 18.7%, sensitivity of 96%, NPV of 97%, PPV of 24%, and a specificity of
29% (Nagappa et al., 2015).
Best Practice Guidelines
In 2012, the ASA determined there was a need to evaluate if their 2006 guidelines
for the perioperative management of patients with OSA were still supported by evidence.
After this review, an updated report was published in 2014. The new report includes
recommendations for preoperative evaluation, preoperative preparation, intraoperative
management, and postoperative management. The SAMBA and SASM concentrate their
guidelines on preoperative screening and management only. These guidelines are not
meant to be implemented as standards or requirements but to merely provide basic
recommendations supported by a synthesis of current literature, expert opinion, open
forum commentary, and clinical data (American Society of Anesthesiologists [ASA],
2014).
Preoperative. To ensure optimal care for patients identified to be at risk for or
who are suspected to have OSA, a protocol should be developed between the anesthesia
provider and the surgeon to make sure these patients are evaluated in the days leading to
surgery to allow preparation for an individualized anesthesia plan (Adesanya, Lee,
11

Greilich, & Joshi, 2010). While a phone interview may offer beneficial information, an
in-person interview and assessment would be preferable as a physical assessment can be
completed. Included in the preoperative evaluation is a comprehensive review of
previous medical records, an interview with the patient or family, and a complete
physical examination (ASA, 2014). Sleep studies should be reviewed when available
(Joshi, Ankichetty, Gan, & Chung, 2012). The SAMBA also advocates for the use of the
STOP-BANG Questionnaire during a preoperative evaluation due to its simplicity to
administer (Joshi et al., 2012).
A complete physical examination should include a detailed oral and nasal airway
assessment, neck circumference, tongue size, and tonsil volume (ASA, 2014). Upon
completion of a thorough preoperative evaluation, any indications of potential OSA
should be noted and jointly reviewed by the anesthesia provider and the surgeon to
determine the best course of action. Based on current clinical evaluations the decision
must be made to either proceed or delay the planned procedure. Proceeding with the
planned procedure will necessitate individualized perioperative management. Often, if
the choice is made to delay the procedure it is due to a need for further studies, more
extensive examinations, and to optimize a patient’s health status. (ASA, 2014).
According to the SASM, initiation of continuous positive airway pressure (CPAP)
should be considered in the preoperative setting when preparing for patients who have
suspected or severe OSA (Chung et al., 2016b). This intervention is believed to possibly
improve apnea time in patients with a decreased functional residual capacity. In contrast
to the guidelines proposed by the ASA and SASM for preparation of OSA patients before
surgery, the SAMBA believes the completion of a sleep study and the use of preoperative
12

CPAP or bi-level positive airway pressure (BiPap) may not improve perioperative
outcomes in this patient population (Joshi et al., 2012). More research is clearly needed
to determine if this intervention is beneficial and what the optimal duration should be.
Intraoperative. The flexibility of the intraoperative anesthesia plan is an
important factor for optimal management of OSA patients. These patients present many
issues the anesthesia provider must concern themselves with such as a choice of
anesthesia technique, airway management, and patient monitoring (ASA, 2014). ASA
members and their consultants agree on the anesthesia management plan presented in the
guidelines, while also acknowledging a lack of current literature and evidence to evaluate
their effects.
Definitive airway management of OSA patients is crucial throughout the surgical
procedure (Brousseau, Dobson, & Milne, 2014). Several studies have shown a
correlation between difficult intubation and OSA patients, while other studies have
reported no relationship (Brousseau et al., 2014). For this reason, emergency airway
devices and equipment should be readily available. For patients at risk for or have OSA
and plan to undergo general anesthesia, guidelines recommend a secure airway (e.g.,
endotracheal tube) over deep sedation without a secure airway (ASA, 2014).
Adesanya and colleagues (2010) stated that the use of sedatives when preparing
for induction of anesthesia should be slowly titrated in OSA patients or avoided entirely.
The use of local anesthesia or peripheral nerve blocks (PNB), with or without moderate
sedation, should be considered for superficial procedures, and spinal or epidural
anesthesia should be used for peripheral procedures (ASA, 2014). CPAP is suggested to
be used during sedation cases if the patient is routinely using these modalities outside of
13

the current surgical setting (ASA, 2014). CPAP will assist in maintaining upper airway
patency.
During the intraoperative anesthesia management of a patient with OSA, the
anesthesia provider must consider the increased risk for respiratory compromise. For this
reason, medications must be chosen carefully due to their potential to affect not only
intraoperative care but because of the medication’s potential to carry over into the
postoperative setting as well. Patients with OSA are shown to have increased
susceptibility to benzodiazepines, volatile anesthetics, and opioids due to their respiratory
depressant effects and should be carefully monitored for postoperative respiratory
compromise (ASA, 2014). The model anesthesia technique would be one in which shortacting medications were used that allow for a prompt return of baseline respiratory
function and patient consciousness (Adesanya et al., 2010). Guidelines explaining a
specific anesthetic drug therapy regimen for patients with suspected or severe OSA have
not been established (Fassbender, Burgener, Haddad, Silvanus, & Peters, 2018).
Emergence from anesthesia can be one of the most daunting aspects for patients
with OSA (Klowden, Nimmagadda, & Salter, 2009). Unless otherwise contraindicated,
patients at risk for OSA should be extubated fully awake, in the lateral, semi-upright, or
other non-supine positions (ASA, 2014). In a study of postoperative positioning in
patients with supine-related OSA, patients placed in a semi-upright position had a
significantly lower AHI when compared to patients in a supine position (Singh et al.,
2015). Emergence can be further complicated when muscle relaxants have been utilized
for surgery. Guidelines strongly suggest extubation only occurring after a full reversal of
any muscle relaxant is verified by a train of four (TOF) nerve stimulation (ASA, 2014).
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TOF nerve stimulation is an intraoperative tool used to assess the degree of paralysis by
neuromuscular blocking agents (NMBAs) (Donati, 2013). Assessment of the ulnar nerve
via the adductor pollicis is best suited for the measurement of recovery from paralyzing
muscle relaxants (Donati, 2013). A twitch response of 0-1 out of 4 indicates 90-100%
nerve blockade and is an indicator of adequate surgical paralysis (Donati, 2013). In
contrast, 4 out of 4 twitches via nerve stimulation indicates a 70% blockade or less and
should be the goal prior to the removal of an endotracheal tube (Donati, 2013).
Postoperative. The postoperative care for the OSA patient should be considered
throughout the perioperative process. A detailed preoperative assessment and meticulous
intraoperative care can assist in negating any potential negative postoperative outcomes
in patients at increased risk related to OSA. To combat postoperative pain, guidelines
encourage the use of regional anesthesia techniques, thus reducing the need for
intravenous (IV) opioid administration (ASA, 2014). Continuous background infusions
should be avoided if patient-controlled IV opioid administration is used for pain
management. The use of caution is recommended when administering opioid analgesics
simultaneously with other sedatives (e.g., benzodiazepines), as the risk for respiratory
depression and airway obstruction is significantly increased (ASA, 2014). Supplemental
oxygen and the use of CPAP in the postoperative setting could be beneficial for those
patients who use these modalities on a regular basis.
If not otherwise contraindicated from the surgical procedure, patients should be
placed in a non-supine position while in the postoperative setting (ASA, 2014). A nonsupine position will help prevent airway obstruction and subsequent oxygen desaturation
in these OSA patients. Upon discharge from the post-anesthesia care unit, continuous
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monitoring to include pulse oximetry should be used to help detect hypoxic events in
those patients admitted to the hospital (ASA, 2014).
To ensure the highest quality care of the patient at increased perioperative risk for
OSA complications, the anesthesia provider should be involved with the
multidisciplinary approach to developing and implementing an individualized and
comprehensive care plan (ASA, 2014). Consensus for these updated ASA guidelines
were obtained from multiple sources, including updated surveys sent to consultants,
testimony from attendees of two national ASA public open forums and ASA task force
opinion and interpretation (ASA, 2014). A search for studies that have implemented all
these best practice guidelines to determine their effectiveness revealed no results. Table
1 is an abbreviated list of the best practice guidelines for the anesthesia management of
OSA patients as determined by the ASA.
Table 1
Best Practices Guidelines for Anesthesia Management of OSA Patients
Preoperative Preparation
•

Preoperative
treatment/optimization
for obstructive sleep
apnea (e.g., continuous
positive airway pressure
[CPAP], noninvasive
positive pressure
ventilation, mandibular
appliances, and medical
treatment)

Intraoperative Management

Postoperative Management

Anesthesia technique
• Local or regional
anesthesia versus
general anesthesia
• Combined regional and
general anesthesia
versus general
anesthesia
• Sedation versus
general anesthesia

Analgesic use
• Regional analgesic
technique without
neuraxial opioids
versus systemic
opioids
• Neuraxial opioids
versus systemic
opioids
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Table Continued
Preoperative Preparation
•

Limit procedures to
facilities with full
hospital services

Intraoperative Management
Monitoring
• Continuously monitor
the respiratory
depressant effects of
sedatives and/or opioids
(e.g., level of
consciousness,
pulmonary ventilation,
oxygenation, and
automated apnea
monitoring)
• Special intraoperative
monitoring techniques
(arterial line,
pulmonary artery
catheter)
Extubation
• Verify full reversal of
neuromuscular block
before extubation
• Extubate patients after
they are fully awake
(vs. asleep or partially
awake)
• Extubate patients in the
semi-upright, lateral, or
prone positions (vs.
supine)
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Postoperative Management
•

Oral analgesics versus
parenteral opioids
• Patient-controlled
analgesia without a
background infusion
versus patientcontrolled analgesia
with a background
infusion
• Titration or lower
dosage levels of
systemic opioids
Oxygenation
• Supplemental oxygen
versus no supplemental
oxygen
• CPAP versus no CPAP
(oxygen or room air)
• CPAP for patients who
had previously been on
CPAP versus CPAP for
patients not previously
on CPAP
• Noninvasive positive
pressure ventilation
versus no noninvasive
positive pressure
ventilation (CPAP,
oxygen, or room air)
Patient positioning
• Lateral, prone, or
tonsil positions versus
the supine position
Monitoring
• Telemetry monitoring
systems versus no
telemetry monitoring
systems
• Monitored setting
versus routine hospital
wards

Pulmonary and Cardiovascular Complications
A systematic review conducted by Opperer et al. (2016) found that OSA is linked
to abnormal airway anatomy predisposing patients to difficult airway management and
intubation. Patients at moderate to severe risk for OSA have a five times greater increase
in intubation and mechanical ventilation after orthopedic surgery and the risk doubles
after general surgery (Opperer et al., 2016). 9261290210354301182487Opperer et al.
(2016) also found an increased incidence of respiratory failure, desaturation episodes
(oxygen saturation < 85%), lengthened hospital stay, and emergent intubation and
mechanical ventilation within the first 24 hours postoperatively. Wolfe et al. (2016)
found that OSA is associated with perioperative respiratory complications such as
pneumonia, pulmonary embolism, reintubation, and pulmonary hypertension which can
lead to an increase in admission to the intensive care unit and length of hospital stay.
These respiratory complications can easily manifest into cardiovascular events in the
OSA patient, arrhythmias, and damaging alterations in the patient’s blood pressure
leading to potential ICU admission.
Rationale
Healthcare organizations are elaborate adaptive systems where change is a
complex process, yet they must respond to an ever-changing environment to maintain
patient safety. Anesthesia practice management requires the implementation of methods
that promote high-quality care based on consensus standards, guidelines, and
performance metrics (Sutton, 2015). The purpose of developed practice guidelines
related to OSA is to improve anesthetic care during surgery and to minimize risks of
adverse outcomes in those patients who have, or who are suspected to have, OSA (ASA,
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2014). Patients receiving anesthetic care include those who receive sedation, anesthesia,
or analgesia for diagnostic or therapeutic procedures while in the care of an anesthesia
provider.
To guide the development and implementation of this project, the logic model
was used. The model consists of four basic components that include inputs, activities,
outputs, and outcomes (CDC, 2018a). What goes into making the quality improvement
project work is having anesthesia providers and/or student registered nurse anesthetists
(SRNAs) educated and available to implement. The resources/inputs included
organization “buy-in” (letter of support from clinical information systems director) and
anesthesia providers implementing STOP-BANG questionnaire. The activities were: (1)
preoperative implementation of STOP-BANG for adult patients having elective surgery
and (2) retrospective chart reviews one month prior to STOP-BANG implementation, the
month of implementation, as well as the month after. The outputs were an increase in the
implementation of an OSA prescreening tool, evaluation of anesthesia management on
adult patients at risk for OSA having elective surgery, and perioperative respiratory and
cardiac complications before, during, and after the implementation of the STOP-BANG
questionnaire. The expected outcomes included identification of potential quality
improvement of OSA anesthesia management, according to best practice guidelines, and
to improve perioperative respiratory and cardiac complications associated with patients at
moderate to severe risk for OSA.
Specific Aims
The overall project consisted of five distinct specific aims. These specific aims
set out to determine the incidence and prevalence of OSA risk at a facility in Southern
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Mississippi, implementation of the STOP-BANG tool, and compare best-practice
guidelines. Following implementation, two more specific aims were to determine
perioperative pulmonary and cardiac complications.
Determining Incidence and Prevalence
The prevalence of patients who had been identified as having moderate or highrisk OSA over a 30-day period was further classified according to age, gender, BMI,
type/length of surgery, and the ASA physical status. The purpose of further classifying
patient demographics and characteristics was to identify trends or patterns so anesthesia
providers would be more aware of which patients were at increased risk of having OSA.
By identifying the number of patients that presented to this facility in Southern
Mississippi over a 30-day period, providers could see how important it was to utilize this
screening tool. This project was part of a larger QI project, and it may lead to an
improvement in the quality of care. Best practice recommendations were made based
upon the results and were intended to lead to decreased post-operative OSA
complications and costs.
Implementation of the STOP-BANG Tool
Another purpose of this project was to implement an effective, evidence-based
OSA screening tool preoperatively to identify patients at risk for OSA and ultimately aid
the anesthesia provider in developing an anesthetic plan of care for each patient. The
implementation of the STOP-BANG questionnaire was then used as a part of the larger
OSA quality improvement project. The STOP-BANG questionnaire was periodically
used in the facility in which implementation took place; however, it was not consistently
used during the pre-anesthetic evaluation.
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Comparing Best-Practice Guidelines
The third purpose of this project was to review anesthetic management of patients
at risk for OSA at a Southern Mississippi hospital and compare it to best practice
guidelines. The previous management was compared to current best practice guidelines.
Practice guidelines assist to improve anesthetic management and decrease the risks of
adverse outcomes.
Postoperative Respiratory and Cardiac Complications
The final two aims of this project were to determine if perioperative respiratory
and cardiac complications decreased. The questionnaire was implemented during the
preoperative screening process via anesthesia providers and/or SRNAs. Postoperative
respiratory complications were defined as hypoxemic events (oxygen saturation <85%),
reintubations in PACU, and admission to the ICU. Postoperative cardiovascular
complications were defined as any arrhythmia (ECG rhythms other than NSR or paced
rhythm), hypotension (SBP < 90 mmHg), and admission to the ICU.
Summary
Symptoms of OSA usually tend to occur at night, leaving the disorder highly
unrecognized. The gold standard for diagnosing OSA is PSG, which is expensive and
inconvenient. Morbidity and mortality are increased with patients having undiagnosed
OSA. Obesity is the most important key factor associated with OSA leaving
Mississippians at high risk due to it being ranked second in the nation for obesity. The
STOP-BANG questionnaire was developed to be a reliable and concise tool to identify
surgical patients at risk for OSA. Numerous studies have revealed that adverse outcomes
are decreased when the STOP-BANG questionnaire is utilized prior to surgery.
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Identification of patients at risk for OSA affords the anesthesia provider a chance to
direct their care accordingly. Practice guidelines serve to improve anesthetic care during
surgery and minimize the risks of adverse outcomes in OSA patients.
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CHAPTER II – METHODS
Context
This quality improvement doctoral project was implemented at a hospital in
Southern Mississippi after approval from The University of Southern Mississippi
Institutional Review Board (IRB). During the time of this project, the facility serviced 19
counties including many southern rural areas often characterized as being older, less
educated, having increased poverty rates, chronic disease, and less economic diversity.
The facility contained 23 operating rooms and conducted approximately 1,140 surgeries
each month.
The demographics of the local county during implementation were 57.2%
Caucasian, 37.3% African American, 0.4% Native American, 1.1% Asian, 0.1% Pacific
Islander, 3.2% Hispanic or Latino, and 1.8% from other races. Roughly 70% of these
patients came from an urban community and the remaining 30% from southern rural
communities (Community Facts, United States Population, 2010). The patients from the
rural community were more likely to develop chronic diseases and be uneducated people
living in poverty. With the lack of education and low income, patients were more likely
to choose unhealthy food options which only further contribute to the obesity epidemic.
Interventions
Education and training for the proper administration of the STOP-BANG
questionnaire were provided to all users (anesthesia providers and/or SRNAs) prior to
administration. Education consisted of a digital slide (PowerPoint, Microsoft)
presentation on the identification of STOP-BANG components and implementers were
trained on how to complete and score the STOP-BANG questionnaire. If any users
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wanted more information about STOP-BANG, its official website, www.stopbang.ca/osa/
screening.php, was provided. Thereafter, the STOP-BANG questionnaire was provided
as a paper copy and incorporated into the preoperative screening process for all adult
elective surgeries over a one-month period. The patients’ medical record numbers were
placed on every STOP-BANG questionnaire. The questionnaire was placed in a locked
box in the preoperative area. The clinical information specialist was the only person with
a key to the box. The patients’ medical record numbers were only used for data
collection related to a retrospective chart review. Demographic data was collected and
reported in aggregation. No personal identifying information was collected and/or
reported. The STOP-BANG score and risk category were written on a brightly colored
sticky note and attached to the anesthesia consent form. Exclusion criteria consisted of
obstetric and emergency surgeries and patients under 18 years of age. Also excluded
were patients admitted to the ICU needing prolonged ventilator management due to these
patients not being extubated during the perioperative setting, per facility protocol. All
data was destroyed after project acceptance and finalization.
Study of the Intervention
Determining Incidence and Prevalence
A retrospective chart review, looking for trends among patients presenting for
surgery that correlated with having a moderate to high-risk score on the STOP-BANG
questionnaires, was conducted to synthesize data obtained over a 30-day period. The
percentage of patients identified as having a moderate to high-risk score on the STOPBANG questionnaires was then compared to the number of patients who presented for
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surgery during the month of October. The calculated prevalence was then compared to
the prevalence of obesity across Mississippi
Implementation of the STOP-BANG Tool
A historical cohort study was used to determine the number of completed STOPBANG questionnaires utilized on patients for the month of implementation and compared
them to the number of surgical patients who met inclusion criteria during the same
month. The percentage of surgeries that meet inclusion criteria which utilized the STOPBANG questionnaire was then reported. Inclusion criteria consisted of elective surgeries
on adult patients excluding emergency, obstetric, and patients under the age of 18.
Comparing Best-Practice Guidelines
The first retrospective chart review took place one month prior to the
implementation of the STOP-BANG questionnaire and included all adult elective surgical
patients that had a BMI of at least 30. The second retrospective chart review took place
the month of implementation of the STOP-BANG questionnaire and included all adult
patients having elective surgery who were identified as having moderate to high risk for
OSA. The third chart review was completed the month following the implementation and
included all adult elective surgical patients who had a BMI of at least 30. By comparing
a BMI greater than or equal to 30, a positive correlation was made to STOP-BANG
scores greater than 3, indicating moderate to severe risk.
Postoperative Respiratory and Cardiac Complications
A one-month historical cohort study was conducted to assess the number and type
of postoperative respiratory and cardiovascular complications prior to the implementation
of the STOP-BANG questionnaire. Postoperative respiratory complications were defined
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as hypoxemic events (oxygen saturation < 85%), reintubations in PACU, and admission
to the ICU. Postoperative cardiovascular complications were defined as any arrhythmia
(ECG rhythms other than NSR or paced rhythm), hypotension (SBP < 90 mmHg), and
admission to the ICU. During and after the one-month implementation of the STOPBANG questionnaire on adult surgical patients who met inclusion criteria, de-identified
requested data was reviewed and compared based on respiratory and cardiovascular
complications.
Measures
Determining Incidence and Prevalence
The de-identified data included patients age, gender, BMI, ASA physical status,
and type/length of surgery. The STOP-BANG score was obtained from the de-identified
STOP-BANG questionnaires. The number of patients identified as at risk for OSA over a
one-month period was noted. The data on these patients were further stratified into low,
moderate, and high risk. The inclusion criteria for the data provided included: cases
performed in the main operating room (OR) and in the GYN OR’s, patient age >50, and
elective procedures.
Implementation of the STOP-BANG Tool
The total number of STOP-BANG questionnaires completed was measured
during the 30-day implementation period. Elective surgeries for patients 18 years or
older who met inclusion criteria were also measured. Thereafter, the analysis was made
based on these measurements from the implementation phase of the STOP-BANG
questionnaire.
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Comparing Best Practice Guidelines
Data for this project included the type of anesthesia provided (general, general
endotracheal anesthesia (GETA), IV sedation, or regional), amount of fentanyl (in
micrograms) used, and the amount of rocuronium used (in milligrams). Data also
included if the paralytic reversal agent Sugammadex was administered and if paralytic
reversal was confirmed by TOF nerve stimulation at the conclusion of the surgical case.
This data was compared between the three retrospective chart reviews and with best
practice guidelines.
Postoperative Respiratory and Cardiac Complications
By comparing a key preoperative variable for OSA (BMI greater than or equal to
30) to STOP-BANG scores greater than 3 (indicates moderate to severe risk), an
assessment was made to see if patients at moderate to severe risk for OSA were at an
increased risk for perioperative respiratory and cardiovascular complications.
Perioperative respiratory complications were listed as hypoxemic events (SaO2 < 85%),
reintubations in PACU, and ICU admission; whereas, cardiac complications were listed
as dysrhythmias, hypotension (SBP < 90), and ICU admission. Demographic data and
patients’ health status (age, ASA score, BMI, gender, type of surgery, etc.) were
compared pre-implementation, during, and post-implementation of the STOP-BANG
questionnaire to eliminate exclusion criteria and gather necessary information related to
perioperative respiratory and cardiovascular events.
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Analysis
Determining Incidence and Prevalence
The data gathered over the 30-day period was analyzed and separated on a
Microsoft Excel® spreadsheet. Descriptive statistics were used to describe the population.
Frequencies were used to determine the prevalence of patients with OSA over a onemonth period. The proportion of patients who were identified as at risk for OSA were
determined by computing the number of patients that presented for surgery over a month
and compared to the number of those identified as moderate or high risk on the STOPBANG questionnaires. The data were further stratified into low-risk, moderate-risk, and
high risk. The national demographics and OSA statistics were compared to the
demographics and statistics at the facility in Southern Mississippi.
Implementation of the STOP-BANG Tool
Data was recorded utilizing Microsoft Excel®. A comparison was made based on
the STOP-BANG questionnaire frequency in relation to the total number of elective
surgeries. Once data was analyzed to ensure inclusion and exclusion criteria were met,
the frequency of completed STOP-BANG questionnaires was calculated as a percentage.
Comparing Best Practice Guidelines
Descriptive statistics and frequencies were used to analyze the data from all three
retrospective chart reviews. Each analysis was reviewed and compared to best practice
guidelines. Data are presented as means and percentages for categorical variables. An
executive summary was created from this data to provide feedback for potential practice
changes, if necessary, according to best practice guidelines for OSA surgical patients.
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Postoperative Respiratory and Cardiac Complications
Data were analyzed utilizing Microsoft Excel® and presented as means with
standard deviation for continuous variables. Categorical variables were reported as
percentages. Continuous and categorical variables were listed and compared to note if
there were any changes in perioperative respiratory and cardiovascular complications
after the implementation of STOP-BANG.
Ethical Considerations
The University of Southern Mississippi IRB approval (18091109) was obtained
prior to initiating the quality improvement project. All patient health information was
protected by the Health Insurance Portability and Accountability Act of 1996. The list of
medical record numbers was kept in locked storage only accessible to the clinical
information specialist. All electronic files containing identifiable information were
password protected to prevent access by unauthorized users. The password was known to
the authors only. All information was properly disposed of after project completion
according to university policy.
DNP Essentials
The Doctor of Nursing Practice (DNP) Essentials outline the central competencies
for all advanced nursing practice roles. The DNP graduate is expected to demonstrate
scholarly activity through a theory-driven research project. The essentials and how they
were met by this doctoral project are listed in Appendix B.
Summary
A local facility in Southern Mississippi did not utilize a prescreening tool for
determining OSA risk factors during the implementation of this quality improvement
29

project. The STOP-BANG questionnaire was provided as a paper copy in the
preoperative setting and completed by SRNAs and/or anesthesia staff during the
preoperative assessment on all patients that met inclusion criteria. The scores were
placed on a brightly colored sticky note and placed on the patient’s chart for visualization
by the anesthesia staff. A one-month retrospective chart review was completed prior to,
during, and after the implementation of the STOP-BANG questionnaire for analysis of
anesthesia management in comparison with best-practice guidelines as well as
perioperative respiratory and cardiovascular complications. The de-identified data was
provided by a facility employee via a password-protected electronic file. This file was
destroyed upon completion of graduation requirements.
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CHAPTER III – RESULTS
Results
Determining Incidence and Prevalence
In October, there were 348 surgical procedures that met the inclusion criteria.
De-identified data was provided by the Director of Clinical Informatics for the month of
October. Seventeen STOP-BANG questionnaires were filled out during October. Of
those 17, only 3 were filled out properly with identifiers to match their STOP-BANG
scores to their ASA physical status and type/length of surgery. From the three surveys,
two were male patients who were identified as being low risk and one was identified as
being a high risk of having sleep apnea. The patient with the high-risk score was in a
laparoscopic umbilical hernia repair that lasted four hours; he was an ASA 2 and had a
BMI of 32.8. One of the patients with a low-risk score was in an insertion of a
ventriculoperitoneal shunt that lasted two hours; he was an ASA 3 and had a BMI of
20.1. The other patient with a low-risk score was in an endoscopic retrograde
cholangiopancreatography laparoscopic cholecystectomy that lasted three hours; he was
an ASA 2 and had a BMI of 32.3. Of the 17 questionnaires, 10 were identified as having
a moderate or high-risk score, 8 were male, and 2 were female.
Implementation of the STOP-BANG Tool
During the month of STOP-BANG implementation, 348 elective surgeries met
inclusion criteria. Seven adult elective surgery patients who met inclusion criteria had
completed STOP-BANG questionnaires. For the purpose of this study, the results of the
frequency of use (implementation) of the STOP-BANG equaled 2%. Of those seven,
only three of the questionnaires could be disseminated for further data due to lack of
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patient identifiers. The ability to adequately assess the ages of patients for which those
questionnaires belonged to, was established by handwritten notation of patient ages on
the STOP-BANG questionnaire by the anesthesia provider at the time of assessment. In
turn, 4 of the questionnaires were deemed to be reliable and fell within the inclusion
criteria. As a result, there was a 2% frequency of use of the STOP-BANG questionnaire
during the preoperative evaluation for the month of implementation.
Comparing Best-Practice Guidelines
De-identified data for the month prior to STOP-BANG implementation, and the
month following was provided by the director of clinical information in a timely manner
as planned. The actual implementation of the questionnaire in the preoperative setting
began and finished per the specified time frame planned, and de-identified data was
subsequently provided as previously described. Due to decreased numbers of completed
STOP-BANG questionnaires for the implementation month, a comparison of anesthesia
care for all adult elective surgeries meeting inclusion criteria was completed for the
month of implementation in addition to those identified as at moderate to severe risk for
OSA, as originally planned.
There were 319 patients having elective surgeries during the month prior to the
STOP-BANG implementation. Of these surgical patients, 38.6% (n=123) were deemed
to have at least a moderate risk for OSA due to a BMI greater than 30. Of this group
(n=123) there were 86 GETA cases, 25 general cases, 8 regional cases, and 4 IV sedation
cases. The average dose of fentanyl, rocuronium, and sugammadex was 145.9 mcg, 37
mg, and 117.6 mg respectively. No surgical case involving administration of the
paralytic, rocuronium, or the paralytic reversal agent, sugammadex, was confirmed to be
32

reversed via TOF nerve stimulation. A total of 14 (11.3%) fentanyl free, 8 (6.5%)
regional, and 4 (3.2%) IV sedation surgical cases occurred during this period
During the month of STOP-BANG implementation, 348 patients having elective
surgeries met inclusion criteria. Of these surgical patients, 42.5% (n=148), were deemed
to have at least a moderate risk for OSA due to a BMI greater than 30. Of this group
(n=148), there were 103 GETA cases, 26 general cases, 8 regional cases, and 11 IV
sedation cases. The average dose of fentanyl, rocuronium, and sugammadex was 139.5
mcg, 38 mg, and 124.4 mg respectively. No surgical case involving administration of the
paralytic, rocuronium, or the paralytic reversal agent, sugammadex, was confirmed to be
reversed via TOF nerve stimulation. A total of 20 (13.5%) fentanyl free, 8 (5.4%)
regional, and 11 (7.4%) IV sedation surgical cases occurred during this period.
During the month of STOP-BANG implementation, 2% (n=7) of the adult
elective surgery patients who met inclusion criteria had completed questionnaires. Of
those, less than 1% (n=3) could be used for data results due to missing patient identifiers.
Of this population (n=3) only 1 patient was identified as a moderate or severe risk for
OSA, with a score of 7. This patient received 250 mcg of fentanyl, 50 mg of rocuronium,
and 200 mg of sugammadex as a paralytic reversal. No TOF nerve stimulation was
performed to confirm the reversal of paralysis.
There were 300 patients having elective surgeries meeting inclusion criteria the
month following STOP-BANG implementation. Of these surgical patients, 34.3%
(n=103) were deemed to have at least a moderate risk for OSA due to a BMI greater than
30. Of this group (n=103), there were 66 GETA cases, 20 general cases, 10 regional
cases, and 7 IV sedation cases. The average dose of fentanyl, rocuronium, and
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sugammadex for this month was 134.2 mcg, 44 mg, and 163.5 mg respectively. No
surgical case involving administration of the paralytic, rocuronium, or the paralytic
reversal agent, sugammadex, was confirmed to be reversed via TOF nerve stimulation. A
total of 16 (15.5%) fentanyl free, 10 (9.7%) regional, and 7 (6.8%) IV sedation surgical
cases occurred during this third month.
Postoperative Respiratory and Cardiac Complications
During the first month of the retrospective chart review, 45.8% out of 319 (n =
146) surgical patients, at a hospital in Southern Mississippi, met the inclusion criteria
(i.e., elective surgical procedure, age greater than 18, and BMI greater than 30). Of these
patients with moderate risk for OSA, there were no reintubations in PACU, 17.8% (n =
26) had a hypoxemic event, 15.1% (n = 22) had an arrhythmia, 17.1% (n = 25)
experienced hypotension, and 11.2% (n = 13) were transferred to the ICU.
Cardiothoracic surgeries and craniotomies were excluded from the ICU transfers due to
these surgeries being transferred there per facility protocol. Detailed demographic and
clinical characteristics prior to the month of STOP-BANG implementation are listed in
Table 2 (respiratory) and Table 3 (cardiac).
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Table 2
Demographics and clinical characteristics prior to implementation of STOP-BANG
(respiratory)

Age, Y, mean (SD)
ASA class, mean (SD)
BMI, mean (SD)
Gender, male, No. (%)
Event total, No. (%)

Hypoxemic
Event
Sao2 < 85%

Reintubation

ICU Transfer

In PACU

68 (1.09)
3.6 (0.63)
37.39 (9.08)
19 (73%)
26 (17.8%)

0
0
0
0
0 (0%)

Excluding
cardiothoracic surgeries
& craniotomies
68.9 (1.63)
3.5 (0.5)
38.8 (2.15)
9 (69%)
13 (11.2%)

Patients with at least a moderate risk for OSA: Abbreviations: ASA, American Society of Anesthesiologist; Y, Years; BMI, Body
Mass Index; No, Number; SD, Standard Deviation; PACU, Post Anesthesia Care Unit;

Table 3
Demographics and clinical characteristics prior to implementation of STOP-BANG
(cardiac)

Age, Y, mean (SD)
ASA class, mean (SD)
BMI, mean (SD)
Gender, male, No. (%)
Event total, No. (%)

Arrhythmias
(Any rhythm
other than NSR
or paced)
65.3 (9.64)
3.5 (0.58)
36.1 (3.98)
15 (68.2%)
22 (15.1%)

Hypotension
(SBP < 90
mmHg)
63.6 (6.90)
3.6 (0.69)
41.3 (10.27)
15 (60.0%)
25 (17.1%)

ICU Transfer
(Excluding
cardiothoracic surgeries
& craniotomies)
68.9 (1.63)
3.5 (0.5)
38.8 (2.15)
9 (69%)
13 (11.2%)

Patients with at least a moderate risk for OSA:
Abbreviations: ASA, American Society of Anesthesiologist; Y, Years; BMI, Body Mass Index; No, Number; SD, Standard Deviation;
PACU, Post Anesthesia Care Unit;

The month of STOP-BANG implementation yielded 48.6% out of 348 (n = 169)
surgical patients that met inclusion criteria. The patients with a moderate risk for OSA
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had no reintubations in PACU, 20% (n = 34) developed a hypoxemic event, 11.2% (n =
19) had an arrhythmia, 16.6% (n = 28) experienced hypotension, and 15.9% (n = 27)
were transferred to the ICU. Cardiothoracic surgeries and craniotomies were excluded
from the ICU transfers due to these surgeries being transferred there per facility protocol.
Detailed demographic and clinical characteristics for the month of STOP-BANG
implementation are listed in Table 4 (respiratory) and Table 5 (cardiac).
Table 4
Demographics and clinical characteristics during the implementation of STOP-BANG
(respiratory)

Age, Y, mean (SD)
ASA class, mean (SD)
BMI, mean (SD)
Gender, male, No. (%)
Event total, No. (%)

Hypoxemic
Event
Sao2 < 85%

Reintubation

ICU Transfer

In PACU

70 (11.27)
3.5 (0.6)
36.87 (5.87)
18 (53%)
34 (24%)

0
0
0
0
0 (0%)

Excluding
cardiothoracic surgeries
& craniotomies
68.15 (10.47)
3.44 (0.5)
35.24 (3.87)
11 (41%)
27 (15.9%)

Patients with at least a moderate risk for OSA:
Abbreviations: ASA, American Society of Anesthesiologist; Y, Years; BMI, Body Mass Index; No, Number; SD, Standard Deviation;
PACU, Post Anesthesia Care Unit;

Table 5
Demographics and clinical characteristics during the implementation of STOP-BANG
(cardiac)

Age, Y, mean (SD)
ASA class, mean (SD)

Arrhythmias
(Any rhythm
other than NSR
or paced)
65.1 (9.02)
2.9 (0.69)

Hypotension
(SBP < 90
mmHg)
65.4 (11.34)
3.6 (0.49)
36

ICU Transfer
(Excluding
cardiothoracic surgeries
& craniotomies)
68.2 (10.47)
3.44 (0.50)

Table Continued
BMI, mean (SD)

BMI, mean (SD)
Gender, male, No. (%)
Event total, No. (%)

Arrhythmias
(Any rhythm
other than NSR
or paced)
35.8 (5.74)
6 (31.6%)
19 (11.2%)

Hypotension
(SBP < 90
mmHg)
36.9 (3.68)
13(46.4%)
28 (16.6%)

ICU Transfer
(Excluding
cardiothoracic surgeries
& craniotomies)
35.2 (3.87)
11 (41%)
27 (15.9%)

Patients with at least a moderate risk for OSA: Abbreviations: ASA, American Society of Anesthesiologist; Y, Years; BMI, Body
Mass Index; No, Number; SD, Standard Deviation; PACU, Post Anesthesia Care Unit;

During the month of STOP-BANG implementation, 2% (n = 7) of the adult
elective surgery patients that met inclusion criteria had completed questionnaires. Of
those, only three could be used for data results due to incomplete data. Thus, just under
1% (n = 3) of questionnaires were available for data collection. One of the three
completed STOP-BANG scores was greater than three (moderate risk for OSA) and none
of these patients had any respiratory complications. One patient did report a history of
HTN but did not experience any perioperative cardiovascular complications including
arrhythmias or hypotension. Demographic and clinical characteristics of patients with
completed STOP-BANG questionnaires are listed in Table 6.
Table 6
Demographics and clinical characteristics of STOP-BANG scores

Age, Y, Mean (SD)
Neck > 16 in for Female, No. (%)
Neck > 17 in for Male, No, (%)
BMI > 30, No. (%)
Gender, male, No. (%)
Snoring, No. (%)

STOP-BANG < 3
(N= 2)
61.5 (6.36)
0 (100%)
0 (100%)

STOP-BANG > 3
(N= 1)
56 (0)
1 (100%)
0 (100%)

0 (100%)
2 (100%)
0 (100%)

1 (100%)
1 (100%)
1 (100%)
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Table Continued

Tiredness, No. (%)
Observed Apnea, No. (%)
HTN, No. (%)
ASA class, mean (SD)
Sao2 < 85%, No. (%)
PACU Intubation, No. (%)
Arrhythmias, No. (%)
Hypotension, No. (%)
ICU Transfer, No. (%)
STOP-BANG score, No. (%)

STOP-BANG < 3
(N= 2)
0 (100%)
0 (100%)
0 (100%)
2.5 (0.7)
0 (100%)
0 (100%)
1 (50%)
0 (100%)
0 (100%)
2 (100%)

STOP-BANG > 3
(N= 1)
1 (100%)
0 (100%)
1 (100%)
2 (0)
0 (100%)
0 (100%)
0 (100%)
0 (100%)
0 (100%)
7 (100%)

Patients with completed STOP-BANG scores: Abbreviations: ASA, American Society of Anesthesiologist; Y, Years; BMI, Body
Mass Index; No, Number; SD, Standard Deviation; PACU, Post Anesthesia Care Unit; SB, STOP-BANG score; HTN, hypertension;
SB, STOP-BANG;

During the final month of the retrospective chart review—the month after STOPBANG implementation—38.8% out of 299 (n = 116) surgical patients met inclusion
criteria. The patients with a moderate risk for OSA had no reintubations in PACU, 22%
(n = 21) developed a hypoxemic event, 6.9% (n = 8) had an arrhythmia, 21.6% (n = 25)
experienced hypotension, and 12.4% (n = 12) were transferred to the ICU.
Cardiothoracic surgeries and craniotomies were excluded from the ICU transfers due to
these surgeries being transferred there per facility protocol. Detailed demographic and
clinical characteristics prior to the month of STOP-BANG implementation are listed in
Table 7 (respiratory) and Table 8 (cardiac).
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Table 7
Demographics and clinical characteristics after the implementation of STOP-BANG
(respiratory)

Age, Y, mean (SD)
ASA class, mean (SD)
BMI, mean (SD)
Gender, male, No. (%)
Event total, No. (%)

Hypoxemic
Event
Sao2 < 85%

Reintubation

ICU Transfer

In PACU

67.2(9.32)
3.42 (0.59
38.42 (8.91)
10 (47%)
21 (22%)

0
0
0
0
0 (0%)

Excluding
cardiothoracic surgeries
& craniotomies
70.3 (6.83)
3.50 (0.5)
37.2 (9.52)
8 (66.7%)
12 (12.4%)

Patients with at least a moderate risk for OSA:
Abbreviations: ASA, American Society of Anesthesiologist; Y, Years; BMI, Body Mass Index; No, Number; SD, Standard Deviation;
PACU, Post Anesthesia Care Unit

Table 8
Demographics and clinical characteristics after the implementation of STOP-BANG
(cardiac)

Age, Y, mean (SD)
ASA class, mean (SD)
BMI, mean (SD)
Gender, male, No. (%)
Event total, No. (%)

Arrhythmias
(Any rhythm
other than NSR
or paced)
67.4 (9.59)
3.1 (0.60)
41.3 (7.29)
1 (12.5%)
8 (6.9%)

Hypotension
(SBP < 90
mmHg)
67.1 (7.54)
3.4 (0.57)
38.0 (8.32)
13 (52.0%)
25 (21.6%)

ICU Transfer
(Excluding
cardiothoracic surgeries
& craniotomies)
70.3 (6.83)
3.50 (0.5)
37.2 (9.52)
8 (66.7%)
12 (12.4%)

Patients with at least a moderate risk for OSA:
Abbreviations: ASA, American Society of Anesthesiologist; Y, Years; BMI, Body Mass Index; No, Number; SD, Standard Deviation;
PACU, Post Anesthesia Care Unit;

Summary
Two percent of surgeries that met inclusion criteria during the month of
implementation had a completed and usable STOP-BANG questionnaire. Therefore, an
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increase in the frequency of use of an OSA prescreening tool (STOP-BANG) was noted
since there was no evidence of a prescreening tool being utilized at this facility prior to
implementation. The results of comparing anesthesia management indicated an overall
decrease in the amount of fentanyl utilized during the month of implementation as well as
the month following. A greater percentage of fentanyl free and IV sedation anesthesia
techniques were utilized during the month of implementation as well as the following
month. The percentage of surgical cases using regional anesthesia increased during the
month after implementation. The amount of rocuronium given for GETA surgical cases
did not drastically change from any month. However, the amount of sugammadex given
per GETA case that received rocuronium paralysis did increase both the month of STOPBANG implementation and the month following. No anesthesia cases utilized
rocuronium for paralysis followed by confirmation of reversal via TOF nerve stimulation
for any of the three months.
De-identified data were compared for the month prior to, during, and after the
implementation of the STOP-BANG questionnaire for respiratory and cardiac
complications. Seven different tables list patient demographics and/or perioperative
respiratory and cardiovascular complications. Data was represented in the tables above
using percentages and means with standard deviation.
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CHAPTER IV DISCUSSION
Summary
Determining Incidence and Prevalence
The prevalence of obesity among adults in Southern Mississippi is greater than
35%. Obesity is a major predictor of patients who are at an increased risk of developing
or already having OSA. Therefore, it can be inferred that a large percentage of patients
presenting for surgery will have OSA. OSA is associated with numerous anesthetic
complications including difficult intubations, difficult mask ventilation, CO2 narcosis,
and rapid desaturation.
Due to the lack of anesthesia provider participation in gathering data, an accurate
prevalence rate cannot be calculated. Using the 17 filled out questionnaires, the
prevalence was calculated as 2.8% because only 10 of those surveys had a moderate or
high-risk STOP-BANG score. The calculated prevalence of moderate to high-risk OSA
patients is inaccurate and does not correlate with the prevalence of obesity in Southern
Mississippi. With Mississippi having the second highest rate of obesity, the STOPBANG questionnaire is an invaluable resource for pre-operative assessments to help
reduce post-operative anesthetic complications.
Implementation of the STOP-BANG Tool
All anesthesia providers (i.e., anesthesiologists, certified registered nurse
anesthetists, and SRNAs) were properly educated the month prior to STOP-BANG
implementation on how to accurately utilize the STOP-BANG questionnaire
preoperatively. Brightly colored pamphlets and postings were made visible throughout
the anesthesia lounge and the same-day surgery unit beginning the month prior to
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implementation through the month of implementation. However, 2% of questionnaires
completed fell within qualifying criteria and less than 1% (n = 3) of the surgeries that met
inclusion criteria had completed questionnaires with useful information for data
collection. Alternatively, the use of preoperative STOP-BANG assessments increased
during the month of implementation and positively correlated with provider education
regarding this topic.
Comparing Best Practice Guidelines
While the originally planned data was not made available through the process of
STOP-BANG implementation, some important nuances of patient anesthetic care were
able to be made and compared month to month. An inference was drawn that the
knowledge of the ongoing project and education may have influenced patient care during
and after the month of implementation. During the month prior to STOP-BANG
implementation, the average dose of fentanyl per surgical case was 145.9 mcg. This
decreased during the implementation month to an average of 139.5 mcg per surgical case,
a 6.4 mcg per case decrease. The month following STOP-BANG implementation had an
average of 134.2 mcg of fentanyl per surgical case. Thus, the average fentanyl dose
decreased by 5.3 mcg from the month of implementation and an 11.7 mcg per surgical
case decrease from the month prior to implementation. The average dose of rocuronium
for GETA cases did not change drastically during the first two months. The average dose
of rocuronium for these cases was 37 mg during the month prior to implementation as
compared to 38 mg for the month of implementation. The month following
implementation showed an average of 44 mg of rocuronium per GETA surgical case.
During the month prior to STOP-BANG implementation, GETA cases received an
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average of 117 mg of sugammadex to reverse rocuronium paralysis. The sugammadex
average increased the following month to 124 mg. The third month showed an average
of 163.5 mg of sugammadex per GETA surgical case.
The data indicated that during these 3 months not all patients receiving more than
the average defasciculating dose (5-10 mg) of rocuronium paralysis were reversed by
sugammadex. It also indicated 0 patients were confirmed fully reversed via TOF nerve
stimulation for any of the three months. The ASA and the American Association of
Nurse Anesthetists (AANA) are clear in their support for extubating a patient only after
full reversal of chemical paralysis is confirmed by TOF nerve stimulation.
Additional data retrieved showed fentanyl free anesthesia increased during the
month of STOP-BANG implementation and the month following to 13.5% and 15.5% of
surgical cases respectively. The occurrence of fentanyl free anesthesia increased
compared to 11.3% during the month prior to implementation. Also, the percentage of
IV sedation cases, allowing patients to maintain spontaneous respirations, increased to
7.4% during the month of implementation. There was also a noted increase of IV
sedation cases during the third month to 6.8% of surgical cases. The increase in IV
sedation cases are a noticeable difference from only 3.2% IV sedation cases the month
before implementation. The month prior to STOP-BANG implementation showed that
6.5% of surgical cases were done under regional anesthesia. The regional anesthesia
percentage declined to 5.4% during the month of implementation and increased to 9.7%
the month following.
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Postoperative Respiratory and Cardiac Complications
During the month of STOP-BANG implementation, perioperative respiratory
complications increased. Hypoxemic events and ICU transfers both increased by 6.2%
and 4.7% respectively. However, there was a 0.4% and 3.5% decrease in hypoxemic
events and ICU transfers respectively when comparing the month of implementation and
post-implementation of STOP-BANG. During the month of STOP-BANG
implementation, arrhythmias (3.9%) and hypotension (0.5%) decreased. While there was
an increase in ICU transfers (4.7%), it is presumed that this increase was not related to
any perioperative cardiovascular complications. During the month after STOP-BANG
implementation, arrhythmias (4.3%) and ICU transfers (3.5%) decreased while
hypotensive events (5.0%) increased. Once again, it is presumed that this increase was
not related to any perioperative complication related to OSA, but rather anesthetic dosage
and/or patient-specific baseline hypotension.
Interpretation
Determining Incidence and Prevalence
Drawing any correlation from such a small patient sample is difficult. The 17
questionnaires that were completed are only representative of 4.8% of the patients who
presented for surgery over the month of October. Using the 10 surveys with a high-risk
score, the prevalence of OSA was 2.8% over a one-month period. A conclusion cannot
be drawn from this sample size to determine that 4.8% is an accurate portrayal of OSA
prevalence in this facility.
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Implementation of the STOP-BANG Tool
The facility in which implementation was performed completed 348 elective
surgeries that met inclusion criteria. Seventeen STOP-BANG questionnaires in total
were collected from the dropbox. Ten of the 17 questionnaires did not meet inclusion
criteria. Four of the 7 questionnaires did not have a patient identifier but did have
handwritten ages on them which met inclusion criteria. For the purpose of this project, 7
of the STOP-BANG questionnaires met the project criteria. After calculations were
made, 2% of completed STOP-BANG questionnaires fell within the defined criteria.
Therefore, the implementation month (30 days) of the STOP-BANG questionnaire at this
facility resulted in a 2% frequency of use when compared to the total number of elective
surgeries that met inclusion criteria.
Comparing Best-Practice Guidelines
The amount of fentanyl used per case during the month of STOP-BANG
implementation decreased by 6.4 mcg and decreased an additional 5.3 mcg the month
following implementation. The fentanyl dose decrease could be attributed to an
increased awareness of patients at risk for OSA during the month of implementation and
their need for decreased narcotic usage. An increase of 6.8 mg in the average dose of
sugammadex per GETA case to reverse chemically paralyzed patients during the month
of implementation was shown. The average dose of sugammadex increased by an
additional 39.5 mg per case during the third month and could be attributed to increased
anesthesia provider awareness as well. The average dose of sugammadex could also be
attributed to the increasing average dose of rocuronium per GETA case during the month
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following implementation. No cases for any month of the project used a TOF nerve
stimulation to confirm the full reversal of chemical paralysis.
An increase of fentanyl free surgical cases for both the month of implementation
and the month following was noted. Fentanyl free surgical cases increased to 13.5%
during the month of implementation and 15.5% the month after. IV sedation cases
increased from 3.2% the month prior to STOP-BANG implementation to 7.4% the month
of, and 6.8% the month following. Regional anesthesia cases fluctuated from month to
month. The month prior to STOP-BANG implementation, 6.5% of surgical cases
primarily utilized regional anesthesia. Regional anesthesia declined to 5.4% during the
month of implementation but subsequently increased the month following to 9.7%.
While these numbers are not dramatic, it is possible the anesthesia provider chose these
anesthesia types due to an increased awareness of patients at risk of OSA. Currently,
there are no studies correlating positive STOP-BANG scores (greater than 3) and changes
in the anesthetic plan in order to reduce perioperative complications.
Postoperative Respiratory and Cardiac Complications
Postoperative respiratory complications during the month of STOP-BANG
implementation increased; hypoxic events by 6.2% and ICU transfers by 4.7%. No
reintubations in the PACU was noted. Perioperative cardiovascular complications,
including arrhythmias and hypotension, decreased during the month of STOP-BANG
implementation—arrhythmias by 3.9% and hypotension by 0.5%. While research shows
there is an increased risk for complications with STOP-BANG scores greater than three,
this quality improvement project showed no type of respiratory compromise and only one
documented rhythm change. Furthermore, there are currently no studies correlating
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positive STOP-BANG scores greater than three with recommended changes in anesthetic
plans to combat perioperative respiratory or cardiovascular complications.
Limitations
Less than 1% of completed questionnaires during the month of STOP-BANG
implementation were usable for this project as originally planned. Due to a lack of buyin, an inference was drawn that anesthesia provider education on current best practice
guidelines for anesthesia care of the OSA patient possibly altered the anesthesia plan, but
this inference cannot be confirmed. Also included as a limitation should be a
consideration that a patient’s comorbidities, outside of OSA, could alter anesthetic care.
Additional limitations include the lack of additional data variables. Fentanyl,
rocuronium, and sugammadex were only anesthetic medications reviewed.
Oxygen desaturation during this quality improvement project could be explained
by several factors other than the moderate risk for OSA: the residual effects of opioids
and neuromuscular blocking drugs, general anesthesia versus regional, and different
demographic data. During this quality improvement project, arrhythmias were
considered any documented ECG reading other than NSR or paced rhythm. The nonNSR ECG was a limitation because, for some patients, sinus tachycardia or bradycardia
may be a normal baseline for their heart rate. The same is true for hypotension (SBP < 90
mmHg); for some patients, hypotension may be considered normal at resting states.
Also, postoperative ICU admissions can be caused by a number of adverse events
occurring other than OSA. Examine the reason for ICU admission and expand exclusion
criteria for these events to focus on OSA related complications would be useful. Finally,
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another limitation to this project was the lack of OSA diagnoses with PSG in patients
with inferred risk for OSA.
Conclusion
The limited number of completed STOP-BANG questionnaires was a limitation to
this project. However, the limited number of STOP-BANG questionnaires did not have
anything to do with the coexisting evidence from the retrospective chart reviews. Data
received provided the opportunity to create an executive summary to provide awareness
to the hospital of any potential practice changes it deems necessary.
Future research should be conducted on how to increase anesthesia provider buyin for a STOP-BANG questionnaire implementation and could also entail a more detailed
look at intraoperative anesthesia care for patients identified as at risk for moderate to
severe OSA. This project should include not only common anesthetic drugs, as in this
project but others as well. For example, other narcotics, benzodiazepines, paralytics, and
reversal agents should be studied and compared to best practice guidelines. Education on
the importance of TOF nerve stimulation to confirm chemical paralysis reversal could
also prove beneficial.
Although there was a lack of anesthesia staff buy-in and participation,
the usefulness of results may guide future researchers and project designers in how to
obtain sustainability in future implementations and practice changes. In this case, the
opportunity for staff and stakeholders to see considerable areas for growth was revealed
by the overall project outcomes. The data may superficially illustrate the lack of
implementation to make profound changes or effects at the facility, but the revelation of
areas needing to be strengthened will supersede this result. Future projects should be
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conducted on how to provide competent and eager staff with the resources and tools
needed to increase staff and student buy-in to facilitate meaningful and sustainable
implementation. This quality improvement project provided evidence that a prescreening
tool for OSA, such as STOP-BANG, is useful to reduce the risk of perioperative
respiratory and cardiovascular complications, especially with Mississippi having the
second highest rate of obesity in the nation.
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APPENDIX A – STOP-BANG Questionnaire
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APPENDIX B – DNP Essentials

I.

Doctor of Nursing Essentials
Scientific Underpinning for
Practice

II.

III.

IV.

V.

VI.

VII.

VIII.

Organizational and Systems
Leadership for Quality
Improvement and Systems
Thinking
Clinical Scholarship and
Analytical Methods for
Evidence-Based Practice
Information
Systems/Technology and
Patient Care Technology for the
Improvement and
Transformation of Health Care
Health Care Policy for
Advocacy in Health Care

Interprofessional Collaboration
for Improving Patient and
Population Health Outcomes
Clinical Prevention and
Population Health for
Improving the Nation’s Health

Advanced Nursing Practice

How the Essential was Achieved
This project uses current evidenced-based
research concerning the STOP-BANG
questionnaire and reducing adverse
patient outcomes.
The objective of this project was to
improve patient outcomes by
implementing a prescreening OSA tool in
the preoperative arena.
Providing a STOP-BANG score for
anesthesia staff via a sticky note on every
patient’s chart that met inclusion criteria.
Deidentified data provided by the facility
employee was analyzed via Microsoft
Excel® This data was given to the facility
for clinical decision making.
An OSA prescreening tool was not
utilized at the facility during
implementation. Negotiations with
multiple facility departments made
implementation of this project possible.
Development, education, and
implementation of the STOP-BANG
questionnaire.
Mississippi ranks 2nd in the nation for
obesity which is a key factor with patients
at risk for OSA. Bringing attention to
anesthesia staff of patient OSA risk has
the potential to change perioperative
adverse outcomes.
The STOP-BANG questionnaire is proven
to decrease perioperative adverse
outcomes associated with OSA.
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